Ms. Kristina Hachey reports

THERALASE(R) ENGAGES GLOBAL ONE MEDIA TO EXPAND GLOBAL INVESTOR AWARENESS

Theralase Technologies Inc. has engaged Global One Media Group Pte. Ltd. to provide digital investor marketing and communications services to the company.

Global One Media is an arm's-length investor marketing firm headquartered in Singapore that specializes in digital investor communications for publicly traded companies. Its services include strategic messaging, video production, social media communications and international distribution across investor-focused media channels.

Commencing Aug. 1, 2026, Global One Media will assist Theralase with an investor awareness program designed to increase the company's visibility and communicate its corporate, scientific and clinical developments to investors across North America, Europe and Asia.

Services may include social media management and distribution, digital distribution of company news releases, content creation, executive interviews, podcasts, corporate video production, investor-focused media features, panel discussions, and targeted digital advertising. All distributed materials concerning Theralase will be based on the company's publicly disclosed information and will be subject to the company's prior review and approval.

Under the agreement, Global One Media will receive a cash fee compensation of $39,000 (U.S.) for a six-month term. Global One Media will not receive any securities as compensation.

To the company's knowledge, neither Global One Media nor its principals currently have any direct or indirect interest in the securities of Theralase or any right or intention to acquire such an interest.

The engagement is subject to customary filings and acceptance by the TSX Venture Exchange.

Roger DuMoulin-White, BSc, PEng, ProDir, president and chief executive officer of Theralase, stated: "As Theralase continues to advance its clinical, regulatory and commercialization objectives, effectively communicating our progress to a broader international investor audience remains an important priority. Global One Media's digital communication capabilities and international investor network are expected to complement our existing investor relations activities and assist the company in expanding its visibility across North America, Europe and Asia."

Bastien Boulay, co-founder and chief executive officer of Global One Media, stated: "Global One Media is delighted to be working with Theralase in expanding its investor relations communications internationally at such a critical tipping point in the company's transformation to a stand-alone pharmaceutical company. Myself and our entire team look forward to working with the Theralase team in the pursuit of this goal."

About Global One Media Group Pte. Ltd.

Global One Media is an investor marketing firm focused on digital investor communications for publicly traded and pre-IPO (initial public offering) companies. Through strategic narrative development, video content and international distribution across its investor media network, Global One Media assists companies in communicating with retail, high-net-worth and institutional investor audiences across North America, Europe and Asia.

About Theralase Technologies Inc.

Theralase is a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses.

We seek Safe Harbor.